Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


25.10.2021

1 AJR Am J Roentgenol
1 Am J Gastroenterol
1 Am J Pathol
12 BMC Cancer
1 BMC Gastroenterol
2 Clin Res Hepatol Gastroenterol
6 Eur Radiol
3 Gastroenterology
2 Hepatology
3 J Gastroenterol Hepatol
2 J Hepatol
1 N Engl J Med
3 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. CHERNYAK V
    Editorial Comment: Transitional or Hepatobiliary Phase Hypointensity Improves Sensitivity Without Loss of Specificity for Pathologically Viable HCC After Locoregional Treatment.
    AJR Am J Roentgenol. 2021 Oct 20. doi: 10.2214/AJR.21.26949.
    PubMed        


    Am J Gastroenterol

  2. WEBER S, Gerbes AL
    Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Am J Gastroenterol. 2021;116:2151-2152.
    PubMed        


    Am J Pathol


  3. This Month in AJP.
    Am J Pathol. 2021;191:1669.
    PubMed        


    BMC Cancer

  4. SUN F, Liu Z, Wang B
    Correlation between low-level viremia and hepatitis B-related hepatocellular carcinoma and recurrence: a retrospective study.
    BMC Cancer. 2021;21:1103.
    PubMed         Abstract available

  5. KE Q, Xiang F, Xiao C, Huang Q, et al
    Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
    BMC Cancer. 2021;21:1117.
    PubMed         Abstract available

  6. KELLEY KC, Grossman KF, Brittain-Blankenship M, Thorne KM, et al
    A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
    BMC Cancer. 2021;21:510.
    PubMed         Abstract available

  7. LU H, Zheng C, Liang B, Xiong B, et al
    Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis.
    BMC Cancer. 2021;21:513.
    PubMed         Abstract available

  8. ZHU D, Ding R, Ma Y, Chen Z, et al
    Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China.
    BMC Cancer. 2021;21:557.
    PubMed         Abstract available

  9. WANG B, Wang S, Ren W
    Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    BMC Cancer. 2021;21:609.
    PubMed         Abstract available

  10. SHARMA V, Sharma A, Raina V, Dabkara D, et al
    Metastatic colo-rectal cancer: real life experience from an Indian tertiary care center.
    BMC Cancer. 2021;21:630.
    PubMed         Abstract available

  11. WU F, Zhang FY, Tan GQ, Chen WJ, et al
    Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
    BMC Cancer. 2021;21:704.
    PubMed         Abstract available

  12. WANG W, Wang X, Yang W, Zhong K, et al
    A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects.
    BMC Cancer. 2021;21:1029.
    PubMed         Abstract available

  13. CHENG S, Yang L, Dai X, Wang J, et al
    The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
    BMC Cancer. 2021;21:1057.
    PubMed         Abstract available

  14. XIA B, Peng J, Enrico T, Lu K, et al
    Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
    BMC Cancer. 2021;21:1084.
    PubMed         Abstract available

  15. ZHAO J, Zhu J, Sun R, Huang C, et al
    Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis.
    BMC Cancer. 2021;21:503.
    PubMed         Abstract available


    BMC Gastroenterol

  16. CAI X, Deng J, Zhou J, Cai H, et al
    Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma.
    BMC Gastroenterol. 2021;21:377.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  17. ABERGEL A, Gasperment M, Nery FG, Buchard B, et al
    Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2020 Apr 17. pii: S2210-7401(20)30089.
    PubMed        

  18. ELKRIEF L, Houssel-Debry P, Ackermann O, Franchi-Abella S, et al
    Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
    Clin Res Hepatol Gastroenterol. 2020 Aug 17. pii: S2210-7401(20)30091.
    PubMed         Abstract available


    Eur Radiol

  19. LU X, Zhou H, Wang K, Jin J, et al
    Comparing radiomics models with different inputs for accurate diagnosis of significant fibrosis in chronic liver disease.
    Eur Radiol. 2021;31:8743-8754.
    PubMed         Abstract available

  20. HAM JH, Yu JS, Choi JM, Cho ES, et al
    Corona enhancement can substitute enhancing capsule in the imaging diagnosis of small (
    Eur Radiol. 2021;31:8628-8637.
    PubMed         Abstract available

  21. FAN W, Guo J, Zhu B, Wang S, et al
    Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS.
    Eur Radiol. 2021;31:8291-8301.
    PubMed         Abstract available

  22. QU Y, Middleton MS, Loomba R, Glaser KJ, et al
    Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
    Eur Radiol. 2021;31:8408-8419.
    PubMed         Abstract available

  23. GRIESER C
    Editorial comment: advances in the evaluation of liver imaging and function with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:8374-8375.
    PubMed        

  24. MARKICH R, Palussiere J, Catena V, Cazayus M, et al
    Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
    Eur Radiol. 2021;31:8302-8314.
    PubMed         Abstract available


    Gastroenterology

  25. PACK M
    Model Organisms Help Define the ABCs of Neonatal Cholestasis.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00636.
    PubMed        

  26. MAAN R, Darwish Murad S, van der Meer AJ
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:371-372.
    PubMed        

  27. LI L, Liu C, Qi X
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:370-371.
    PubMed        


    Hepatology

  28. SANYAL AJ, Anstee QM, Trauner M, Lawitz EJ, et al
    Cirrhosis Regression is Associated with Improved Clinical Outcomes in Patients with Nonalcoholic Steatohepatitis.
    Hepatology. 2021 Oct 18. doi: 10.1002/hep.32204.
    PubMed         Abstract available

  29. ZHOU J, Guo L, Ma T, Qiu T, et al
    N-Acetylgalactosaminyltransferase-4 protects against hepatic ischaemia/reperfusion injury via blocking ASK1 N-terminal dimerization.
    Hepatology. 2021 Oct 18. doi: 10.1002/hep.32202.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  30. YIM HJ, Kim W, Ahn SH, Jung YK, et al
    Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2021 Oct 15. doi: 10.1111/jgh.15710.
    PubMed         Abstract available

  31. HUO TI, Ho SY, Liao JI
    Improved patient survival in hepatitis C virus-related hepatocellular carcinoma: Do direct-acting antivirals play a role?
    J Gastroenterol Hepatol. 2021 Oct 15. doi: 10.1111/jgh.15707.
    PubMed        

  32. NAKATSU G
    Toward a postbiotic era of microbiome science: opportunities to advance immunotherapies for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2021 Oct 19. doi: 10.1111/jgh.15715.
    PubMed         Abstract available


    J Hepatol

  33. LAN T, Hu Y, Hu F, Li H, et al
    Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.
    J Hepatol. 2021 Oct 14. pii: S0168-8278(21)02105.
    PubMed         Abstract available

  34. WHITFIELD JB, Schwantes-An TH, Darlay R, Aithal GP, et al
    A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.
    J Hepatol. 2021 Oct 13. pii: S0168-8278(21)02111.
    PubMed         Abstract available


    N Engl J Med

  35. GARCIA-TSAO G
    Nonalcoholic Steatohepatitis - Opportunities and Challenges.
    N Engl J Med. 2021;385:1615-1617.
    PubMed        


    PLoS One

  36. DE MUNCK TJI, Boesch M, Verhaegh P, Masclee AAM, et al
    Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?
    PLoS One. 2021;16:e0251822.
    PubMed         Abstract available

  37. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias.
    PLoS One. 2021;16:e0249194.
    PubMed         Abstract available

  38. LEMIEUX S, Buies A, F Turgeon A, Hallet J, et al
    Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0247958.
    PubMed         Abstract available


    Transplant Proc

  39. MIESZCZANSKI P, Gorniewski G, Blaszczyk B, Pacholczyk M, et al
    Copeptin (CTproAVP) - A Biomarker of a Circulatory Impairment in Liver Transplant Recipients? A Prospective, Observational Study.
    Transplant Proc. 2021 Jul 6. pii: S0041-1345(21)00428.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: